VT-1953 treatment significantly reduced malignant fungating wound-associated malodor (primary endpoint) (P<0.001). Patients also reported significant improvements in lesion pain (P<0.001) and Quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback